INTELLECTUAL PROPERTY
Philips v. Bathla: Why Claim Mapping and Solid Evidence Matter
Our latest blog post delves into the recent judgment of the Delhi High Court in the Philips v. Bathla case.
November 19, 2025
Our latest blog post delves into the recent judgment of the Delhi High Court in the Philips v. Bathla case.
Roche’s plea seeking an interim injunction to restrain Natco Pharma from manufacturing or selling the drug Risdiplam was recently dismissed. This article unpacks key aspects of the case.
In this post, we unpack key features of the revised CRI Guidelines, which were released on July 29, and outline takeaways for inventors.
Read the critical analysis of the legislative framework that governs the orphan drugs industry in India.
This article maps the legislative and judicial developments that shaped the Indian Patent Law in 2019.
The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner.
This website is meant solely for the purpose of providing general information and not for advertising or soliciting any work whether directly or indirectly. By accessing this website, www.foxmandal.in, you acknowledge and confirm that you are seeking information relating to Fox Mandal of your own accord. Further, any content provided in this website should not be construed as legal advice. We disclaim all liability for any consequences of any action taken by the user relying on content provided on the website.
By clicking on the “I Accept” button, the user acknowledges that:
To learn more about how we use cookies, please read our Privacy Policy